Illuminating the genome
RNA-guided endonuclease - in situ labelling, a new CRISPR/Cas9 based molecular visualisation method
Takayoshi Ishii, Andreas Houben
The discovery of the type II clustered regularly interspaced short palindromic repeats (CRISPR)-associated caspase 9 (Cas9) system has been a milestone in the field of targeted genome editing. Initially derived from the bacterium Streptococcus pyogenes, the RNA/protein-complex now is an established tool for targeted genome-editing in eukaryotes.
Whilst its scissor-like properties have yielded a broad range of applications, scientists from the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK Gatersleben) are now using CRISPR/Cas9 in a new cytogenetic method for shining a light into eukaryote genomes - RNA-guided endonuclease - in situ labelling (RGEN-ISL).
For the last 30 years, Fluorescence in situ hybridization (FISH) has been the established and commonly used method for visualising in-situ DNA-sequences at chromosomal level. However, this method requires denaturation of the investigated DNA, thus often damaging the structure of the sample. By basing the RGEN-ISL method on CRISPR-Cas9, IPK researchers managed to bypass the denaturation-step of FISH whilst simultaneously integrating the desired fluorescent labelling properties of the conventional FISH-method. As the new cytogenetic tool preserves the structure of the sample, it opens up the option of investigating the spatio-temporal structure of the genome.
Further experimentation showed that RGEN-ISL outperforms conventional method combinations, such as FISH and immunohistochemistry, requiring less preparation and being comparatively quicker and cheaper. Additionally, the new method functions over a broad temperature-range of 4°C to 37°C and can also be combined with additional protein-detection and imaging methods. A further merit is that RGEN-ISL allows for real-time visualisation of the CRISPR/Cas9-mediated DNA-labelling, therefore revealing the kinetics of the reaction.
So far, the researchers have tested RGEN-ISL in plant samples, but also in human chromosomes, illustrating that their new method can likely be applied within all organisms. Currently, the use of method is limited to repetitive DNA-sequences, as often found in plant genomes. However, Dr Takayoshi Ishii, now working at Tottori University (Japan), who conceived the initial idea behind RGEN-ISL, assumes that this method could be adapted to visualise even single-copy sequences in the future.